Investors

Press Releases

All Releases

View Summary Regeneron to Report First Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on May 8, 2014
Apr 11, 2014
PDF 8.6 KB Add to Briefcase
View Summary Robert A. Ingram Elected to Regeneron Board of Directors
Apr 4, 2014
PDF 12.9 KB Add to Briefcase
View Summary Regeneron Announces Initiative for STEM Education in Hudson Valley
Apr 3, 2014
PDF 14.4 KB Add to Briefcase
View Summary Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study
Apr 1, 2014
PDF 17.2 KB Add to Briefcase
View Summary Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session
Mar 27, 2014
PDF 22.9 KB Add to Briefcase
View Summary Bayer HealthCare and Regeneron Announce Regulatory Submission of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Japan
Mar 3, 2014
PDF 19.6 KB Add to Briefcase
View Summary Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for the Treatment of Macular Edema Following Branch Retinal Vein Occlusion
Feb 24, 2014
PDF 17.8 KB Add to Briefcase
View Summary Regeneron Announces Upcoming 2014 Investor Conference Presentations
Feb 14, 2014
PDF 8.6 KB Add to Briefcase
View Summary Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results
Feb 11, 2014
PDF 42.8 KB Add to Briefcase
View Summary Two-Year Results From Phase 3 VISTA Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Feb 10, 2014
PDF 21.4 KB Add to Briefcase
View Summary Regeneron to Report Fourth Quarter and Full Year 2013 Financial and Operating Results and Host Conference Call and Webcast on February 11, 2014
Jan 21, 2014
PDF 8.6 KB Add to Briefcase
View Summary Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration
Jan 13, 2014
PDF 14.8 KB Add to Briefcase
View Summary Regeneron Launches New Human Genetics Initiative
Jan 13, 2014
PDF 13.4 KB Add to Briefcase
View Summary Regeneron and Geisinger Health System Announce Major Human Genetics Research Collaboration
Jan 13, 2014
PDF 16.7 KB Add to Briefcase
View Summary Regeneron Announces Amendment to Investor Agreement with Sanofi
Jan 13, 2014
PDF 11.5 KB Add to Briefcase
View Summary Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program
Dec 19, 2013
PDF 18.4 KB Add to Briefcase
View Summary Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Dec 18, 2013
PDF 18.5 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the 32nd Annual J. P. Morgan Healthcare Conference
Dec 17, 2013
PDF 8.3 KB Add to Briefcase
View Summary Regeneron Announces Upcoming 2013 Investor Conference Presentation
Dec 4, 2013
PDF 8.3 KB Add to Briefcase
View Summary Sanofi and Regeneron's Dupilumab Named "Clinical Advance of the Year" by Scrip Intelligence
Nov 25, 2013
PDF 15.5 KB Add to Briefcase
Showing 1-20 of 215 Page: 1 2 3 4 5 ... 11  Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)